Clinical trial
Application of a Novel Synbiotic to Modulate the Human Gut Microbiota and Improve Health
NCT02355210 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of a Novel Synbiotic to Modulate the Human Gut Microbiota and Improve Health
- Lead sponsor
- Rush University Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- October 31, 2015
- Enrollment
- 151 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intestinal microbiota and barrier function